Embedded Files
You are here: > Thyroid NZ Home > Thyroid news
Latest news
Latest news
Call for study participants (with medically diagnosed autoimmune disease and within the 18-30 age bracket), read more here.
Eltroxin (levothyroxine) 50 mcg and 100 mcg tablets: Medicine update (Pharmac, 18 April 2024)
Aspen NZ, the supplier of Eltroxin (levothyroxine), has informed Pharmac that the 50 mcg and 100 mcg tablets are changing. Click the above link for more information.
Covid-19 news
Covid-19 news
For (more) COVID-19 related news, please, visit our Thyroid and COVID-19 page.
Older news
Older news
Selenium supplementation shows thyroid benefits (Medscape, 19 February 2024)
News from previous years
News from previous years
Study: Adams, R., Oh, E. S., et al. (2023). Endogenous and exogenous thyrotoxicosis and risk of incident cognitive disorders in older adults. JAMA Intern Med, 183(12),1324 –1331
AFT Carbimazole (section 29) - delisted (Pharmac, Update NZ Pharmaceutical Schedule - Effective 1 March 2021) (NOTE: this brand was temporarily added to the Pharmaceutical Schedule when Neo-Mercazole was out of stock.)
Updated: Compliance: Personal Importation of Medicines (Medsafe, Revised: 1 January 2021)
Updated: Compliance: Importing Medicines - Frequently Asked Questions (Medsafe, Revised: 2 February 2021)
Monitoring Communication: Potential interaction between fluoxetine and levothyroxine (Medsafe, Updated 10 December 2020/Published 21 May 2020)
Medicine recall: Nature-Throid / Whole thyroid tablets (17 September 2020)
Some medicines need to be prescribed by brand (Medsafe, Prescriber Update 40(4): 68-69, December 2019)
Help make medicines safer: Promoting awareness of suspected side effects (Ministry of Health, 19 November 2018)
Dangers of purchasing medicines online highlighted (Medsafe, 25 October 2018)
AFT Carbimazole (section 29) new listing (Pharmac, Update NZ Pharmaceutical Schedule - Effective 1 February 2017)
Page updated
Google Sites
Report abuse